Item 2. PROPERTIES

3K characters. Original on sec.gov · Markdown

Item 2. PROPERTIES

Our corporate headquarters are located at 530 Herman O. West Drive, Exton, Pennsylvania. This building also houses our North American sales and marketing, administrative support and customer service functions, as well as laboratories.

The following table summarizes production facilities by segment and geographic region. All facilities shown are owned except where otherwise noted.



Packaging Systems
Manufacturing:				Contract Analytical Laboratory:
	North American Operations				North American Operations
		United States				United States
			Clearwater, FL				Exton, PA
			Jersey Shore, PA
			Kearney, NE	Mold-and-Die Tool Shops:
			Kinston, NC		North American Operations
			Lititz, PA			United States
			St. Petersburg, FL (1)				Upper Darby, PA

	South American Operations				European Operations
		Brazil				England
			Sao Paulo				Bodmin (2)

	European Operations
		Denmark		Delivery Systems
			Horsens	Manufacturing:
					North American Operations
		England				United States
			St. Austell				Frankfort, IN (2)
							Grand Rapids, MI
		France					Phoenix, AZ (2)
			Le Nouvion				Scottsdale, AZ (2)(3)
							Tempe, AZ (2)
		Germany					Williamsport, PA
			Eschweiler (1)
			Stolberg			Puerto Rico
							Cayey
		Serbia
			Kovin		European Operations
						France
	Asia Pacific Operations						Le Vaudreuil (2)
		China
			Qingpu			Ireland
							Dublin (2)
		India
			Sri City

		Singapore
			Jurong


(1)	This manufacturing facility is also used for research and development activities.


(2)	This facility is leased in whole or in part.


(3)	This manufacturing facility is also used for mold and die production.

Our Delivery Systems segment leases facilities located in Israel, New Jersey and Texas for research and development, as well as other activities. Sales offices in various locations are leased under short-term arrangements.

In October 2014, we announced plans to expand our global manufacturing operations to include a new facility in Waterford, Ireland, which will produce packaging components for insulin injector cartridges and other high-value packaging components. Construction is planned to begin in 2015, subject to the project obtaining requisite planning and zoning approvals.

Previous: Item 1A. RISK FACTORS · Next: Item 3. LEGAL PROCEEDINGS